Related references
Note: Only part of the references are listed.Enhanced Creative Thinking under Dopaminergic Therapy in Parkinson Disease
Achinoam Faust-Socher et al.
ANNALS OF NEUROLOGY (2014)
Treatment of Psychosis and Dementia in Parkinson's Disease
Jennifer G. Goldman et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
Roberto Cilia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J. Garcia-Ruiz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Jeffrey Cummings et al.
LANCET (2014)
I Finally See What You See: Parkinson's Disease Visual Hallucinations Captured With Functional Neuroimaging
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2014)
Naltrexone for impulse control disorders in Parkinson disease A placebo-controlled study
Kimberly Papay et al.
NEUROLOGY (2014)
Hypomania and mania related to dopamine replacement therapy in Parkinson's disease
Franziska Maier et al.
PARKINSONISM & RELATED DISORDERS (2014)
Visual complaints and visual hallucinations in Parkinson's disease
Prabitha Urwyler et al.
PARKINSONISM & RELATED DISORDERS (2014)
Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study
G. Gibson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
K. Ray Chaudhuri et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease
Ashok Sriram et al.
JOURNAL OF NEUROLOGY (2013)
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
Margarita Pondal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Levodopa Infusion Improves Impulsivity and Dopamine Dysregulation Syndrome in Parkinson's Disease
Maria Jose Catalan et al.
MOVEMENT DISORDERS (2013)
Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study
Kangdi Zhu et al.
MOVEMENT DISORDERS (2013)
Dopamine Overdose Hypothesis: Evidence and Clinical Implications
David E. Vaillancourt et al.
MOVEMENT DISORDERS (2013)
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
David Okai et al.
NEUROLOGY (2013)
Pathological gambling in Parkinson's disease. A comprehensive review
Gabriella Santangelo et al.
PARKINSONISM & RELATED DISORDERS (2013)
Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease
Adriana Moro et al.
PARKINSONISM & RELATED DISORDERS (2013)
Hallucinations in Parkinson's disease: cross-sectional study
Marina Svetel et al.
ACTA NEUROLOGICA BELGICA (2012)
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours
Eugenie Lhommee et al.
BRAIN (2012)
Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease
Domenico Bosco et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease
Santiago Perez-Lloret et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Finasteride Attenuates Pathological Gambling in Patients With Parkinson Disease
Marco Bortolato et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease
Stephanie Bannier et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease
Soojeong Shin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Combined Delusional Misidentification Syndrome in a Patient With Parkinson's Disease
Steven P. Cercy et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale
Daniel Weintraub et al.
MOVEMENT DISORDERS (2012)
Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome
Sarah J. Moum et al.
PLOS ONE (2012)
Testing an aetiological model of visual hallucinations in Parkinson's disease
David A. Gallagher et al.
BRAIN (2011)
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
Sean S. O'Sullivan et al.
BRAIN (2011)
Management of punding in Parkinson's disease: an open-label prospective study
A. Fasano et al.
JOURNAL OF NEUROLOGY (2011)
Feeling of presence in Parkinson's disease
Gilles Fenelon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Pedophilic Behavior from Brain Disease
Mario Mendez et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Impulsive and compulsive behaviors in Parkinson's disease: A one-year follow-up study
Asuncion Avila et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
The Prevalence and Clinical Characteristics of Punding in Parkinson's Disease
Ashley H. Spencer et al.
MOVEMENT DISORDERS (2011)
Comparative Neuropsychological Profile of Pathological Gambling, Hypersexuality, and Compulsive Eating in Parkinson's Disease
Carmine Vitale et al.
MOVEMENT DISORDERS (2011)
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease
C. W. Hicks et al.
PARKINSONISM & RELATED DISORDERS (2011)
Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy
Chie Usui et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Hallucinations and REM sleep behaviour disorder in Parkinson's disease: Dream imagery intrusions and other hypotheses
Raffaele Manni et al.
CONSCIOUSNESS AND COGNITION (2011)
Pathological Gambling in Parkinson Disease Is Reduced by Amantadine
Astrid Thomas et al.
ANNALS OF NEUROLOGY (2010)
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Christina A. Rabinak et al.
ARCHIVES OF NEUROLOGY (2010)
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Elin B. Forsaa et al.
ARCHIVES OF NEUROLOGY (2010)
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Benedicte Ballanger et al.
ARCHIVES OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Marked Improvement of Psychotic Symptoms After Electroconvulsive Therapy in Parkinson Disease
Satoshi Ueda et al.
JOURNAL OF ECT (2010)
Zonisamide in managing impulse control disorders in Parkinson's disease
Pedro Emilio Bermejo et al.
JOURNAL OF NEUROLOGY (2010)
Epidemiology of psychosis in Parkinson's disease
Gilles Fenelon et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Nonmotor fluctuations in Parkinson's disease: Clinical spectrum and classification
Kemal Bayulkem et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Insights into pathophysiology of punding reveal possible treatment strategies
A. Fasano et al.
MOLECULAR PSYCHIATRY (2010)
Clozapine for Medication-Related Pathological Gambling in Parkinson Disease
Alessandro Rotondo et al.
MOVEMENT DISORDERS (2010)
Punding in Parkinson's Disease: The Impact of Patient's Awareness on Diagnosis
Alfonso Fasano et al.
MOVEMENT DISORDERS (2010)
Frontal and Associative Visual Areas Related to Visual Hallucinations in Dementia with Lewy Bodies and Parkinson's Disease with Dementia
Cristina Sanchez-Castaneda et al.
MOVEMENT DISORDERS (2010)
Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
Philippe Huot et al.
MOVEMENT DISORDERS (2010)
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD
T. van Eimeren et al.
NEUROLOGY (2010)
Hallucinations and sleep disorders in PD Ten-year prospective longitudinal study
Christopher G. Goetz et al.
NEUROLOGY (2010)
Long term follow-up of Parkinson's disease patients with impulse control disorders
Melis Sohtaoglu et al.
PARKINSONISM & RELATED DISORDERS (2010)
The role of dopamine in bipolar disorder
David A. Cousins et al.
BIPOLAR DISORDERS (2009)
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinsons patients
Nikoletta Bodi et al.
BRAIN (2009)
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease
Shen-Yang Lim et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity
Jaime Kulisevsky et al.
JOURNAL OF NEUROLOGY (2009)
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
Valerie Voon et al.
LANCET NEUROLOGY (2009)
Treatment of Hypersexuality in Parkinson's Disease with Carbamazepine-A Case Report
Jan-Philipp Bach et al.
MOVEMENT DISORDERS (2009)
Inappropriate Sexual Behaviors in Cognitively Impaired Older Individuals
David R. R. Guay
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
Medications used to treat Parkinson's disease and the risk of gambling
A. Imamura et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Impact of standard of care for psychosis in Parkinson disease
T. R. Thomsen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia
Javier Pagonabarraga et al.
MOVEMENT DISORDERS (2008)
Amantadine may reverse punding in Parkinson's disease - Observation in a patient
Kenichi Kashihara et al.
MOVEMENT DISORDERS (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
The relationship between impulsivity and impulse control disorders in Parkinson's disease
Ioannis U. Isaias et al.
MOVEMENT DISORDERS (2008)
Long-term follow-up of impulse control disorders in Parkinson's disease
Eugenia Mamikonyan et al.
MOVEMENT DISORDERS (2008)
Sexual dysfunction in Parkinson's disease
Giuseppe Meco et al.
PARKINSONISM & RELATED DISORDERS (2008)
Topiramate in managing impulse control disorders in Parkinson's disease
Pedro Emilio Bermejo
PARKINSONISM & RELATED DISORDERS (2008)
Fregoli syndrome, associated with levodopa treatment
Jonathan T. Stewart
MOVEMENT DISORDERS (2008)
Predictors of punding in Parkinson's disease: Results from a questionnaire survey
Andrew J. Lawrence et al.
MOVEMENT DISORDERS (2007)
Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series
David A. Gallagher et al.
MOVEMENT DISORDERS (2007)
Stereotyped behavior or punding in Parkinson's disease
Hideto Miwa
JOURNAL OF NEUROLOGY (2007)
Cerebral atrophy in Parkinson's disease patients with visual hallucinations
B. Ramirez-Ruiz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Bernard Ravina et al.
MOVEMENT DISORDERS (2007)
Punding prevalence in Parkinson's disease
Janis M. Miyasaki et al.
MOVEMENT DISORDERS (2007)
Selective diplopia in Parkinson's disease: A special subtype of visual hallucination?
Angelika Nebe et al.
MOVEMENT DISORDERS (2007)
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease
H. M. M. Smeding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism
Roger Kurlan et al.
NEUROLOGY (2007)
Effect of quetiapine a double-blind in psychotic Parkinson's disease patients: Labeled study of 3 months' duration
Jose M. Rabey et al.
MOVEMENT DISORDERS (2007)
Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease
Valerie Voon et al.
ARCHIVES OF NEUROLOGY (2007)
Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease
Fabio Bandini et al.
PARKINSONISM & RELATED DISORDERS (2007)
Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study
Jaime Kulisevsky et al.
MOVEMENT DISORDERS (2007)
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia
Antonino Cannas et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Punding and dyskinesias
Laura Silveira-Moriyama et al.
MOVEMENT DISORDERS (2006)
Prevalence of pathological gambling in patients with Parkinson's disease
Maurizio Avanzi et al.
MOVEMENT DISORDERS (2006)
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
Joseph H. Friedman et al.
MOVEMENT DISORDERS (2006)
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Claire Ardouin et al.
MOVEMENT DISORDERS (2006)
Clinical features associated with impulse control disorders in Parkinson disease
Gregory Pontone et al.
NEUROLOGY (2006)
Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases
T. S. Mandat et al.
ACTA NEUROCHIRURGICA (2006)
What is the evidence for a premorbid parkinsonian personality: A systematic review
Lianna Ishihara et al.
MOVEMENT DISORDERS (2006)
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2006)
Prospective prevalence of pathologic gambling and medication association in Parkinson disease
V Voon et al.
NEUROLOGY (2006)
Compulsive drug use linked to sensitized ventral striatal dopamine transmission
AH Evans et al.
ANNALS OF NEUROLOGY (2006)
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
JM Miyasaki et al.
NEUROLOGY (2006)
Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease
H Matsui et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2006)
Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies
UP Mosimann et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Hallucinations in Parkinson disease in the prelevodopa era
G Fénelon et al.
NEUROLOGY (2006)
Apolipoprotein epsilon 4 advances appearance of psychosis in patients with Parkinson's disease
B Feldman et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
AH Evans et al.
NEUROLOGY (2005)
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease
C Pacchetti et al.
MOVEMENT DISORDERS (2005)
Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study
DR Williams et al.
LANCET NEUROLOGY (2005)
Factors associated with drug-induced visual hallucinations in Parkinson's disease
S Papapetropoulos et al.
JOURNAL OF NEUROLOGY (2005)
Pathological gambling caused by drugs used to treat Parkinson disease
ML Dodd et al.
ARCHIVES OF NEUROLOGY (2005)
Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease:: Relationship to dementia and hallucinations
R Camicioli et al.
MOVEMENT DISORDERS (2005)
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
T Witjas et al.
MOVEMENT DISORDERS (2005)
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
WG Ondo et al.
MOVEMENT DISORDERS (2005)
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients
D Grossi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
KJ Klos et al.
PARKINSONISM & RELATED DISORDERS (2005)
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease
FR Pezzella et al.
MOVEMENT DISORDERS (2005)
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
AH Evans et al.
MOVEMENT DISORDERS (2004)
Genetic polymorphisms subjects in Parkinson disease subjects with or without hallucinations - An analysis of the cholecystokinin system
JG Goldman et al.
ARCHIVES OF NEUROLOGY (2004)
Rivastigmine for dementia associated with Parkinson's disease
M Emre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aripiprazole for drug-induced psychosis in Parkinson disease: Preliminary experience
HH Fernandez et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Clozapine in drug induced psychosis in Parkinson's disease:: a randomised, placebo controlled study with open follow up
P Pollak et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
AD Lawrence et al.
LANCET NEUROLOGY (2003)
Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum
M Gerlach et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease
J Wang et al.
PHARMACOGENETICS (2003)
A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
KJ Black et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mania following deep brain stimulation for Parkinson's disease
J Kulisevsky et al.
NEUROLOGY (2002)
Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease
AJ Harding et al.
BRAIN (2002)
Olanzapine treatment for dopaminergic-induced hallucinations
WG Ondo et al.
MOVEMENT DISORDERS (2002)
Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling
T Witjas et al.
NEUROLOGY (2002)
Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline
DE Riley
CLINICAL NEUROPHARMACOLOGY (2002)
Behavioural disorders, Parkinson's disease and subthalamic stimulation
JL Houeto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
The clinical profile of nonmotor fluctuations in Parkinson's disease patients
DI Gunal et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2002)
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
AJ Harding et al.
BRAIN (2002)
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: A case series
R Bullock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
D Aarsland et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2001)
Genetic variation analysis in Parkinson disease patients with and without hallucinations - Case-control study
CG Goetz et al.
ARCHIVES OF NEUROLOGY (2001)
Olanzapine and clozapine - Comparative effects on motor function in hallucinating PD patients
CG Goetz et al.
NEUROLOGY (2000)
Hallucinations, REM sleep, and Parkinson's disease - A medical hypothesis
I Arnulf et al.
NEUROLOGY (2000)
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
G Giovannoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors
G Fénelon et al.
BRAIN (2000)
Share Paper
